215 related articles for article (PubMed ID: 25586022)
1. In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.
Kim KS; Kim T; Pan JG
J Antibiot (Tokyo); 2015 Jun; 68(6):395-8. PubMed ID: 25586022
[No Abstract] [Full Text] [Related]
2. Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination.
Kassamali Z; Prince RA; Danziger LH; Rotschafer JC; Rhomberg PR; Jones RN
Antimicrob Agents Chemother; 2015 Dec; 59(12):7823-5. PubMed ID: 26392511
[TBL] [Abstract][Full Text] [Related]
3. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
[TBL] [Abstract][Full Text] [Related]
5.
Chen H; Li H; Liu Z; Li J
Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
[TBL] [Abstract][Full Text] [Related]
7. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
8. Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
Carlson-Banning KM; Chou A; Liu Z; Hamill RJ; Song Y; Zechiedrich L
PLoS One; 2013; 8(7):e69646. PubMed ID: 23936064
[TBL] [Abstract][Full Text] [Related]
9. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
[TBL] [Abstract][Full Text] [Related]
11. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
Jones RN; Anderegg TR; Swenson JM;
J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydrazinylethylidenepyrimidines effective against multidrug-resistant Acinetobacter baumannii: Synthesis and in vitro biological evaluation of antibacterial, radical scavenging and cytotoxic activities.
Figueiredo J; Serrano JL; Soares M; Ferreira S; Domingues FC; Almeida P; Silvestre S
Eur J Pharm Sci; 2019 Sep; 137():104964. PubMed ID: 31233866
[TBL] [Abstract][Full Text] [Related]
13. Combination of polymyxin B and meropenem eradicates persister cells from Acinetobacter baumannii strains in exponential growth.
Gallo SW; Ferreira CAS; de Oliveira SD
J Med Microbiol; 2017 Aug; 66(8):1257-1260. PubMed ID: 28721845
[No Abstract] [Full Text] [Related]
14. Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology.
Sands M; McCarter Y; Sanchez W
Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):521-2. PubMed ID: 17558487
[No Abstract] [Full Text] [Related]
15. Antibacterial activity of Lamiaceae plant extracts in clinical isolates of multidrug-resistant bacteria.
Assis FV; Siqueira FL; Gonçalves IE; Lacerda RP; Nascimento RA; Araújo SG; Andrade JT; Herrera KMS; Lima LARS; Ferreira JMS
An Acad Bras Cienc; 2018; 90(2):1665-1670. PubMed ID: 29668795
[TBL] [Abstract][Full Text] [Related]
16. Mucin Binding Reduces Colistin Antimicrobial Activity.
Huang JX; Blaskovich MA; Pelingon R; Ramu S; Kavanagh A; Elliott AG; Butler MS; Montgomery AB; Cooper MA
Antimicrob Agents Chemother; 2015 Oct; 59(10):5925-31. PubMed ID: 26169405
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
Wareham DW; Bean DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):825; author reply 825-6. PubMed ID: 16436759
[No Abstract] [Full Text] [Related]
18. Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
Cerceo E; Deitelzweig SB; Sherman BM; Amin AN
Microb Drug Resist; 2016 Jul; 22(5):412-31. PubMed ID: 26866778
[TBL] [Abstract][Full Text] [Related]
19. In vitro potency of various polymyxin B components.
Tam VH; Cao H; Ledesma KR; Hu M
Antimicrob Agents Chemother; 2011 Sep; 55(9):4490-1. PubMed ID: 21709096
[No Abstract] [Full Text] [Related]
20. Synergistic effects of miconazole and polymyxin B on microbial pathogens.
Pietschmann S; Hoffmann K; Voget M; Pison U
Vet Res Commun; 2009 Aug; 33(6):489-505. PubMed ID: 19085068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
